Income statement
USD
Annual
| Metric | 2025 | 2024 | 2023 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 4M | 23M | 39M | 39M | 48M |
| Gross Profit | -1M | 5M | 8M | 9M | 11M |
| Operating Income | -8M | -14M | -8M | -4M | 69K |
| EBITDA | -14M | -22M | -8M | -2M | 2M |
| Net Income | 701K | -23M | -9M | -5M | 230K |
| EPS (Diluted) | — | — | — | — | — |
Technology
Live Price
Offline$0.73
-2.67% today
1Y Change
-71.54%
Window
Jun 23, 2025 → Jun 16, 2026
Coverage: 247 bars · Jun 23, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Algorhythm Holdings, Inc. (RIME) is a Technology stock with listed on NASDAQ. The stock last traded around $0.73 and down 71.5% across the available one-year price window (Jun 23, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of -81.3%, EPS growth of -153.4%, a dividend yield of 0.0%. What stands out right now is revenue -81.3%, EPS -153.4%, free cash flow +15.1% with operating margin -117.8% and ROIC -89.2%. Valuation is more restrained than many high-expectation growth names at price/sales 0.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines RIME price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RIME
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RIME Max Drawdown
-82.47%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RIME and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$47.5M
+20.9% YoY
FY Net Income
$230.0K
+105.0% YoY
Free Cash Flow
-$2.1M
-271.1% YoY
Revenue Growth
-81.3%
EPS Growth
-153.4%
Gross Margin
6.2%
Net Margin
-196.3%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 4M | 23M | 39M | 39M | 48M |
| Gross Profit | -1M | 5M | 8M | 9M | 11M |
| Operating Income | -8M | -14M | -8M | -4M | 69K |
| EBITDA | -14M | -22M | -8M | -2M | 2M |
| Net Income | 701K | -23M | -9M | -5M | 230K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2M | 8M | 7M | 3M | 7M |
| Total Assets | 13M | 18M | 28M | 17M | 34M |
| Total Liabilities | 15M | 29M | 20M | 6M | 22M |
| Shareholder Equity | -117K | -9M | 8M | 10M | 12M |
| Total Debt | 11M | 650K | 4M | 736K | 11M |
| Net Debt | 10M | -7M | -3M | -2M | 3M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
2M
-509.7% YoY
Capital Expenditures
118K
+51.6% YoY
Free Cash Flow
2M
-271.1% YoY
Key ratios
Gross Margin
6.2%
Operating Margin
-117.8%
Net Margin
-196.3%
ROE
-613.4%
Debt / Equity
-97.45x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.